GlassScriptPhysician profile
Emily J Cannon
NPI 1720319130
$4,329.98
in general payments reported to CMS, 2019-2025
15 companies · $1,522 in 2025
The $1,522 reported for 2025 was more than what 92% of Acute Care (Nurse Practitioner) providers received nationally (typical 2025 total: $151).
See the full distribution for Acute Care (Nurse Practitioner)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $562 · 2022: $672 · 2023: $580 · 2024: $994 · 2025: $1,522.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,745 · Travel and Lodging: $351.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,744.65 |
| Travel and Lodging | $350.73 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $960.89 | 2022-2025 | Cardiomems |
| Cvrx, INC. | $811.42 | 2025 | Barostim Neo System |
| Novartis Pharmaceuticals Corporation | $810.54 | 2021-2025 | |
| Astrazeneca Pharmaceuticals LP | $690.14 | 2022-2025 | Farxiga, Lokelma |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $282.67 | 2022-2024 | Lifevest |
| Boehringer Ingelheim Pharmaceuticals, INC. | $200.65 | 2021-2025 | Jardiance |
| E.R. Squibb & Sons, L.L.C. | $179.89 | 2023-2025 | Camzyos |
| Impulse Dynamics (USA) INC. | $111.51 | 2024 | Optimizer |
| Biosense Webster, INC. | $68.38 | 2024 | Carto 3 |
| Pfizer INC. | $66.54 | 2021 | |
| Boston Scientific Corporation | $57.00 | 2025 | General - Therapies |
| Lexicon Pharmaceuticals, INC. | $30.24 | 2023-2024 | Inpefa |
| Janssen Pharmaceuticals, INC | $26.12 | 2024 | Xarelto |
| Sanofi-Aventis U.S. LLC | $22.90 | 2024 | |
| Amgen INC. | $11.09 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Emily Cannon listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.